Kovack Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.5M | Sell |
2,652
-229
| -8% | -$147K | 0.08% | 242 |
|
|
2025
Q4 | $1.95M | Buy |
2,881
+127
| +5% | +$86.5K | 0.09% | 210 |
|
|
2025
Q3 | $1.76M | Sell |
2,754
-30
| -1% | -$18.2K | 0.17% | 117 |
|
|
2025
Q2 | $1.49M | Buy |
2,784
+71
| +3% | +$34K | 0.15% | 134 |
|
|
2025
Q1 | $1.14M | Hold |
2,713
| – | – | 0.12% | 159 |
|
|
2024
Q4 | $1.12M | Buy |
2,713
+5
| +0.2% | +$2.19K | 0.11% | 157 |
|
|
2024
Q3 | $1.37M | Hold |
2,708
| – | – | 0.14% | 122 |
|
|
2024
Q2 | $1.32M | Buy |
2,708
+57
| +2% | +$28.6K | 0.15% | 138 |
|
|
2024
Q1 | $1.43M | Buy |
2,651
+26
| +1% | +$14.2K | 0.17% | 114 |
|
|
2023
Q4 | $1.46M | Buy |
+2,625
| New | +$1.23M | 0.17% | 123 |
|
|
2023
Q3 | – | Sell |
-1,484
| Closed | -$745K | – | 582 |
|
|
2023
Q2 | $745K | Buy |
1,484
+84
| +6% | +$40.3K | 0.1% | 205 |
|
|
2023
Q1 | $700K | Sell |
1,400
-107
| -7% | -$51.2K | 0.1% | 211 |
|
|
2022
Q4 | $615K | Sell |
1,507
-159
| -10% | -$61.7K | 0.09% | 234 |
|
|
2022
Q3 | $543K | Sell |
1,666
-489
| -23% | -$180K | 0.08% | 263 |
|
|
2022
Q2 | $756K | Sell |
2,155
-625
| -22% | -$255K | 0.1% | 219 |
|
|
2022
Q1 | $1.52M | Sell |
2,780
-280
| -9% | -$147K | 0.16% | 142 |
|
|
2021
Q4 | $2.02M | Sell |
3,060
-171
| -5% | -$107K | 0.19% | 120 |
|
|
2021
Q3 | $2.01M | Sell |
3,231
-2,242
| -41% | -$1.51M | 0.22% | 118 |
|
|
2021
Q2 | $3.46M | Sell |
5,473
-91
| -2% | -$50.2K | 0.39% | 57 |
|
|
2021
Q1 | $2.72M | Sell |
5,564
-3,259
| -37% | -$1.63M | 0.35% | 72 |
|
|
2020
Q4 | $4.41M | Buy |
8,823
+290
| +3% | +$130K | 0.63% | 22 |
|
|
2020
Q3 | $3.35M | Buy |
8,533
+9
| +0.1% | +$3.33K | 0.6% | 34 |
|
|
2020
Q2 | $2.81M | Sell |
8,524
-737
| -8% | -$213K | 0.55% | 39 |
|
|
2020
Q1 | $2.24M | Buy |
9,261
+193
| +2% | +$50.4K | 0.52% | 42 |
|
|
2019
Q4 | $2.37M | Sell |
9,068
-266
| -3% | -$70.1K | 0.42% | 56 |
|
|
2019
Q3 | $2.54M | Buy |
9,334
+655
| +8% | +$182K | 0.52% | 40 |
|
|
2019
Q2 | $2.39M | Buy |
+8,679
| New | +$2.14M | 0.55% | 40 |
|
|
2019
Q1 | – | Sell |
-4,976
| Closed | -$926K | – | 473 |
|
|
2018
Q4 | $926K | Sell |
4,976
-1,753
| -26% | -$359K | 0.27% | 89 |
|
|
2018
Q3 | $1.68M | Buy |
6,729
+3,411
| +103% | +$828K | 0.43% | 55 |
|
|
2018
Q2 | $723K | Buy |
3,318
+42
| +1% | +$8.65K | 0.2% | 128 |
|
|
2018
Q1 | $627K | Buy |
+3,276
| New | +$605K | 0.16% | 157 |
|
Other funds holding IDXX
VCM
VPM
Kovack Advisors's IDXX Position: Q1 2026 in Review
Kovack Advisors reduced its Idexx Laboratories (IDXX) stake by 7.9% in Q1 2026, selling an estimated $147K and leaving 2,652 shares worth $1.5M. The position accounts for 0.08% of the portfolio, ranked #242.
Kovack Advisors first reported a position in IDXX in Q1 2018 and has held it in 31 quarters since. The position peaked at $4.41M in Q4 2020. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Kovack Advisors held 2,652 shares of Idexx Laboratories worth $1.5M as of Q1 2026.
- Kovack Advisors sold 229 Idexx Laboratories shares in Q1 2026, an estimated $147K.
- Idexx Laboratories made up 0.08% of Kovack Advisors's portfolio in Q1 2026, its #242 holding.
- Kovack Advisors first reported a position in Idexx Laboratories in Q1 2018 and has held it in 31 quarters since.
- Kovack Advisors's Idexx Laboratories position peaked at $4.41M in Q4 2020.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.